Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide ... year – once-weekly injections of tirzepatide at three dose levels – 5, 10, and 15 mg – achieved a 94% reduction ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist ... news that Wegovy and two other semaglutide products – Ozempic and Rybelsus for type 2 diabetes – have been ...

While Ozempic is effective, it is not suitable for everyone. Here are some common reasons why individuals and healthcare providers may look for substitutes: Dual forms of Chromium (Picolinate ...

Ozempic is a medication that’s receiving attention for its role in weight loss. It works by helping control appetite and blood sugar levels. But knowing what dose of Ozempic is best for weight ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

Sure, who wouldn’t want to lose a few pounds? But what’s really driving Hollywood’s latest trend is the drug’s seemingly miraculous side benefits ...

Some people who use semaglutide (Ozempic, others) have noted sagging skin in the buttocks, calling it “Ozempic butt.” While lifestyle modifications may help prevent this weight loss side ...